Literature DB >> 2891803

Benefits of treatment of mild to moderate hypertension.

C H Hennekens1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2891803     DOI： 10.1007/bf02596375

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  27 in total

1.  Five-year survival of patients with malignant hypertension treated with antihypertensive agents.

Authors:  E R MOHLER; E D FREIS
Journal:  Am Heart J       Date:  1960-09       Impact factor: 4.749

Review 2.  The community-based randomized trials of pharmacologic treatment of mild-to-moderate hypertension.

Authors:  P R Hebert; N H Fiebach; K A Eberlein; J O Taylor; C H Hennekens
Journal:  Am J Epidemiol       Date:  1988-03       Impact factor: 4.897

3.  Implications of overviews of randomized trials.

Authors:  C H Hennekens; J E Buring; P R Hebert
Journal:  Stat Med       Date:  1987 Apr-May       Impact factor: 2.373

4.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

5.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

6.  Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

Authors:  A Amery; W Birkenhäger; P Brixko; C Bulpitt; D Clement; M Deruyttere; A De Schaepdryver; C Dollery; R Fagard; F Forette
Journal:  Lancet       Date:  1985-06-15       Impact factor: 79.321

7.  MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

8.  Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1979-12-07       Impact factor: 56.272

9.  Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.

Authors:  A Helgeland
Journal:  Am J Med       Date:  1980-11       Impact factor: 4.965

10.  Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1982-02-05       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.